Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Potential Utility of Prebiotics to Modulate Alzheimer’s Disease: A Review of the Evidence
Jea Woo Kang, Angela M. Zivkovic
Microorganisms (2021) Vol. 9, Iss. 11, pp. 2310-2310
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Obesity and Bone: A Complex Relationship
Giuseppe Rinonapoli, Valerio Pace, Carmelinda Ruggiero, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13662-13662
Open Access | Times Cited: 156
Activation of aryl hydrocarbon receptor (AhR) in Alzheimer’s disease: role of tryptophan metabolites generated by gut host-microbiota
Antero Salminen
Journal of Molecular Medicine (2023) Vol. 101, Iss. 3, pp. 201-222
Open Access | Times Cited: 53
Gut Microbiota, an Additional Hallmark of Human Aging and Neurodegeneration
Natalia Molinero, Alejandro Antón‐Fernández, Félix Hernández, et al.
Neuroscience (2023) Vol. 518, pp. 141-161
Open Access | Times Cited: 51
The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline
James Melrose
Antioxidants (2023) Vol. 12, Iss. 3, pp. 663-663
Open Access | Times Cited: 42
The human gut microbiome and aging
Evan S. Bradley, John P. Haran
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Gut microbiota in Alzheimer’s disease: Understanding molecular pathways and potential therapeutic perspectives
Simone Lista, Antonio Munafò, Filippo Caraci, et al.
Ageing Research Reviews (2025) Vol. 104, pp. 102659-102659
Closed Access | Times Cited: 2
Biopharmaceutical applications of microbial polysaccharides as materials: A Review
Yige Song, Shuxin Li, Gong Hao, et al.
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124259-124259
Closed Access | Times Cited: 33
Influence of human gut microbiome on the healthy and the neurodegenerative aging
Alejandro Borrego-Ruiz, Juan J. Borrego
Experimental Gerontology (2024) Vol. 194, pp. 112497-112497
Open Access | Times Cited: 11
Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease
Vasu Peddinti, Manoj Mohan Avaghade, Sunil Suthar, et al.
Clinical Nutrition ESPEN (2024) Vol. 60, pp. 266-280
Closed Access | Times Cited: 8
Implications of gut and oral microbiota in neuroinflammatory responses in Alzheimer's disease
Laura Bello-Corral, Lisa Alves-Gomes, Jesús Antonio Fernández-Fernández, et al.
Life Sciences (2023) Vol. 333, pp. 122132-122132
Open Access | Times Cited: 20
Molecular mechanism and therapeutic strategy of bile acids in Alzheimer’s disease from the emerging perspective of the microbiota–gut–brain axis
Menglu Wu, Yongyi Cheng, Ruolin Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117228-117228
Open Access | Times Cited: 6
Gut microbial metabolism in Alzheimer's disease and related dementias
Jea Woo Kang, Vaibhav BV Vemuganti, Jessamine F. Kuehn, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00470-e00470
Open Access | Times Cited: 6
Prebiotics Beyond the Gut: Omics Insights, Artificial Intelligence, and Clinical Trials in Organ-Specific Applications
I.S.I. Al-Adham, Ahmed S.A. Ali Agha, Faisal Al‐Akayleh, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement
Cristina Popescu, Constantin Munteanu, Aurelian Anghelescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11272-11272
Open Access | Times Cited: 3
Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials
Kelly Jimin Park, Yao Gao
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 3
Reversing and modulating cellular senescence in beta cells, a new field of opportunities to treat diabetes
María F. Rubín de Celis, Susan Bonner‐Weir
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 7
Multi-Omic Analyses Reveal Bifidogenic Effect and Metabolomic Shifts in Healthy Human Cohort Supplemented With a Prebiotic Dietary Fiber Blend
Jea Woo Kang, Xinyu Tang, Charles J. Walton, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 11
The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology
Meenakshi Dhanawat, Garima Malik, Kashish Wilson, et al.
CNS & Neurological Disorders - Drug Targets (2024) Vol. 24, Iss. 1, pp. 7-20
Closed Access | Times Cited: 2
The Role of the Gut Microbiome in Neurological Diseases
Ti-Ara Turner, Ashutosh K. Mangalam
Elsevier eBooks (2024)
Closed Access | Times Cited: 1
Iron Fortification and Inulin Supplementation in Early Infancy: Evaluating the Impact on Iron Metabolism and Trace Mineral Status in a Piglet Model
Jungjae Park, Saumya Wickramasinghe, David A. Mills, et al.
Current Developments in Nutrition (2024) Vol. 8, Iss. 4, pp. 102147-102147
Open Access | Times Cited: 1
Elevated lipopolysaccharide binding protein in Alzheimer’s disease patients with APOE3/E3 but not APOE3/E4 genotype
Eduardo Z. Romo, Brian V. Hong, Rishi Y. Patel, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Interconnections between the Gut Microbiome and Alzheimer’s Disease: Mechanisms and Therapeutic Potential
Ahmad M Sait, Philip J. Day
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8619-8619
Open Access | Times Cited: 1
Body Composition and Alzheimer’s Disease: A Holistic Review
Giulia Frank, Paola Gualtieri, Rossella Cianci, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9573-9573
Open Access | Times Cited: 1
The Neuropathological Impacts of COVID-19: Challenges and Alternative Treatment Options for Alzheimer’s Like Brain Changes on Severely SARS-CoV-2 Infected Patients
Md. Rashidur Rahman, Raushanara Akter, Sharmind Neelotpol, et al.
American Journal of Alzheimer s Disease & Other Dementias® (2023) Vol. 38
Open Access | Times Cited: 3
A New Insight on Feasibility of Pre-, Pro-, and Synbiotics-based Therapies in Alzheimer’s Disease
Marjan Talebi, Vida Ebrahimi, Ahmadreza Rasouli, et al.
Journal of Reports in Pharmaceutical Sciences (2022) Vol. 11, Iss. 2, pp. 141-155
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top